Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01809808 · ClinicalTrials.gov registry record
A Prospective Study of Outcome After Therapy for Acromegaly
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 280
- Enrollment target
NCT01809808 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 280 participants.
The verdict
NCT01809808 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 280 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate hormone values and other markers of disease activity in a cohort of patients with acromegaly at the time of diagnosis and then prospectively after surgical or other treatment. This study is designed to determine blood levels of growth hormone and related hormones and cardiovascular risk markers as well as signs and symptoms of the disease at diagnosis and how these parameters change over time after surgical or other therapy. The investigators will also obtain hormonal data in a group of 50 healthy subjects who will each be studied just once with an oral glucose tolerance test (OGTT). These data will provide a comparison group to the acromegaly subjects.
Interventions
- PROCEDURE Adipose Tissue Biopsy
- PROCEDURE Surgery for acromegaly
- DRUG Medications for acromegaly
- DIAGNOSTIC_TEST Total body magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2003-09 |
| Est. Completion | 2025-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01809808
The ClinicalTrials.gov registry entry for NCT01809808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Adipose Tissue Biopsy is the first listed.
NCT01809808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01809808 about?
NCT01809808 is a clinical study titled "A Prospective Study of Outcome After Therapy for Acromegaly". The purpose of this study is to evaluate hormone values and other markers of disease activity in a cohort of patients with acromegaly at the time of diagnosis and then prospectively after surgical or other treatment. This study is designed to determine blood levels of growth hormone and related horm...
What is the current status of trial NCT01809808?
This trial is currently completed. The enrollment target is 280 participants. The study started on 2003-09. Estimated completion is 2025-08.
What interventions are being tested in trial NCT01809808?
The interventions under investigation include: Adipose Tissue Biopsy (PROCEDURE), Surgery for acromegaly (PROCEDURE), Medications for acromegaly (DRUG), Total body magnetic resonance imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01809808?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.